Your browser is no longer supported. Please, upgrade your browser.
AWH Aspira Women's Health Inc. daily Stock Chart
Aspira Women's Health Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own1.80% Shs Outstand97.29M Perf Week4.42%
Market Cap439.17M Forward P/E- EPS next Y- Insider Trans129.83% Shs Float44.37M Perf Month27.38%
Income-15.20M PEG- EPS next Q- Inst Own23.10% Short Float11.48% Perf Quarter127.92%
Sales5.00M P/S87.83 EPS this Y-8.50% Inst Trans1.99% Short Ratio4.91 Perf Half Y471.87%
Book/sh0.05 P/B89.80 EPS next Y- ROA-103.50% Target Price- Perf Year594.29%
Cash/sh0.08 P/C54.22 EPS next 5Y- ROE-155.20% 52W Range0.35 - 5.78 Perf YTD454.32%
Dividend- P/FCF- EPS past 5Y19.90% ROI-152.80% 52W High-22.32% Beta3.48
Dividend %- Quick Ratio2.50 Sales past 5Y12.50% Gross Margin30.40% 52W Low1180.66% ATR0.36
Employees52 Current Ratio2.50 Sales Q/Q50.00% Oper. Margin- RSI (14)59.91 Volatility6.66% 7.54%
OptionableYes Debt/Eq0.25 EPS Q/Q22.60% Profit Margin- Rel Volume0.30 Prev Close4.48
ShortableYes LT Debt/Eq0.21 Earnings- Payout- Avg Volume1.04M Price4.49
Recom- SMA2012.50% SMA5012.23% SMA200159.17% Volume312,694 Change0.22%
Jul-31-20 09:23AM  
Jul-08-20 06:30AM  
Jul-01-20 11:23AM  
Jun-29-20 08:00AM  
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. The company serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHULER JACK W10% OwnerJul 01Buy3.502,285,7158,000,00325,394,517Jul 06 05:25 PM